Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Urinary Bladder Neoplasms 1Thyroid Nodule 1Thyroid Neoplasms 1Thyroid Diseases 1Pruritus 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Parathyroid Neoplasms 1Parathyroid Diseases 1Opioid-Related Disorders 1Non-Muscle Invasive Bladder Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lung Neoplasms 1Lower Urinary Tract Symptoms 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Goiter 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Cancer Cachexia 1Brain Neoplasms 1Agnosia 1Adenocarcinoma of Lung 1

Interventions

methylnaltrexone 1acetaminophen, codeine drug combination 1Ultrasonic Waves 1Tramadol 1Tirzepatide 1Therapeutics 1Standard of Care 1Psilocybin 1Olanzapine 1Midazolam 1Lidocaine 1Educational Status 1Dosage Forms 1Capsules 1Buprenorphine, Naloxone Drug Combination 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Opioid-Related Disorders × Capsules × Clear all
NCT03469310 2021-05-11

Minimizing Narcotic Analgesics After Endocrine Surgery

DHR Health Institute for Research and Development

Phase 4 Completed
126 enrolled
Head & Neck

Agnosia, Goiter, Opioid-Related Disorders, Parathyroid Diseases, Parathyroid Neoplasms, Thyroid Diseases, Thyroid Neoplasms, Thyroid Nodule

Data powered by HemOnc (CC BY 4.0) Colophon âš¡